Page 5 - Keun Seo News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Girls Generation s Seohyun, Ma Dong Seok, and Lee David Confirmed to Lead the Upcoming Film The Holy Night: Demon Hunters
kdramastars.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kdramastars.com Daily Mail and Mail on Sunday newspapers.
Voice 4 Director Explains Theme Of New Season s Villain + Song Seung Heon And Kang Seung Yoon Talk About Joining The Cast
soompi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from soompi.com Daily Mail and Mail on Sunday newspapers.
WINNER’s Kang Seung Yoon and Son Eun Seo are joining the fourth season of OCN’s thriller “Voice“!
“Voice,” which aired its first season in 2017, revolves around an emergency call center and the employees who attempt to fight crime using the limited information they get from the urgent calls they receive. The upcoming season will pit the Golden Time Team against a vicious murderer with extraordinary hearing abilities that rival their own. Song Seung Heon and Lee Ha Na were previously confirmed to be starring in the drama’s fourth season.
On April 27, it was revealed that WINNER’s Kang Seung Yoon and Son Eun Seo were also cast in “Voice 4.”
February 26, 2021
New data from an observational study provide some support for antiplatelet therapy in patients with moyamoya disease, a rare arteriopathy characterized by progressive stenosis of the distal internal carotid artery and other basal cerebral arteries.
Patients with moyamoya disease prescribed antiplatelet therapy, tracked through the Korean National Health Insurance Service (NHIS) database, had a significantly lower risk of death than those who didn’t receive antiplatelet therapy (HR 0.77; 95% CI 0.70-0.84). The largest reduction in mortality was seen in patients who were prescribed the phosphodiesterase inhibitor cilostazol (HR 0.57; 95% CI 0.49-0.68).
Based on their findings, “antiplatelet therapy generally, and cilostazol particularly, shows observational evidence of potential benefit as medical treatment for patients with moyamoya disease,” write Woo-Keun Seo, MD, PhD (Samsung Medical Center, Seoul, South Korea), and colleagues in their study published Feb
vimarsana © 2020. All Rights Reserved.